Literature DB >> 33317666

The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study.

H Zhang1, X Cao1, D Wang2, H Xin1, Z Liu2, J Yan2, B Feng1, Z Quan1, Y Du1, J Liu3, L Guan3, F Shen3, X Guan3, Q Jin1, S Pan2, L Gao1.   

Abstract

BACKGROUND: Occupational exposure-related risk of Mycobacterium tuberculosis infection has been reported for village doctors in China. This prospective study aims to estimate the infection acquisition in this key population.
METHODS: At baseline, all village doctors registered in Zhongmu County were tested by QuantiFERON®-TB Gold In-Tube (QFT) and QuantiFERON®-TB Gold Plus (QFT-Plus) in parallel. Those negatives for either of the tests were retested to identify conversions at the 2-year follow-up investigation.
RESULTS: A total of 367 eligible participants completed the 2-year follow-up survey with frequency of conversion of 5.0% (18/361) for QFT and 6.1% (21/343) for QFT-Plus. The agreement of follow-up results between the tests was 93.2% with a κ coefficient of 0.43 (95%CI 0.20-0.65). Among QFT-Plus convertors, the difference between TB1 and TB2 tubes (TB2-TB1) was significantly increased as compared with baseline results (P = 0.039). Participants from the villages with occurrence of microbiologically confirmed pulmonary TB showed higher frequency of QFT conversions (11.0% vs. 3.2%, P = 0.011) and QFT-Plus conversions (12.3% vs. 4.4%, P = 0.027) than those from the villages without occurrence.
CONCLUSION: Our results consistently suggest that capability on occupational protection and M. tuberculosis infection control should be improved in village doctors in China.

Entities:  

Mesh:

Year:  2020        PMID: 33317666     DOI: 10.5588/ijtld.20.0153

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  Tuberculosis among resident doctors and nurses in a tertiary care hospital: A case-control study.

Authors:  Yuvaraj B Chavan; Priyanka S Shenoy
Journal:  J Family Med Prim Care       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.